Asia Medical and Agricultural Laboratory and Research Center Public (AMARC) Fundamentals 2026 — P/E 8.5x, Revenue Analysis | SniperIQ
Asia Medical and Agricultural Laboratory and Research Center Public (AMARC) is a TH-listed Industrials company in Specialty Business Services with a market capitalization of ฿1.3B, trading at ฿3.14 on the SET. This SniperIQ fundamentals page covers Asia Medical and Agricultural Laboratory and Research Center Public's valuation (P/E 8.5x, P/B 2.2x), profitability (net margin 32.0%), revenue (฿491M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Asia Medical and Agricultural Laboratory and Research Center Public's market cap?
Asia Medical and Agricultural Laboratory and Research Center Public (AMARC) has a market capitalization of approximately ฿1.3B, trading at ฿3.14 on the SET. Market cap moves with the live share price.
What is Asia Medical and Agricultural Laboratory and Research Center Public's P/E ratio?
Asia Medical and Agricultural Laboratory and Research Center Public's trailing twelve-month P/E ratio is 8.5x, with a price-to-book (P/B) of 2.2x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Asia Medical and Agricultural Laboratory and Research Center Public?
Asia Medical and Agricultural Laboratory and Research Center Public runs a net profit margin of 32.0%, a gross margin of 53.6%, and an operating margin of 31.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Asia Medical and Agricultural Laboratory and Research Center Public generate?
Asia Medical and Agricultural Laboratory and Research Center Public reported revenue of ฿491M for fiscal year 2025, with net income of ฿159M and earnings per share (EPS) of 0.38. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Asia Medical and Agricultural Laboratory and Research Center Public pay a dividend?
Asia Medical and Agricultural Laboratory and Research Center Public offers a trailing dividend yield of about 8.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Asia Medical and Agricultural Laboratory and Research Center Public financially healthy?
Asia Medical and Agricultural Laboratory and Research Center Public carries a debt-to-equity ratio of 0.03x and a current ratio of 5.09x, with a market beta of 0.44. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Asia Medical and Agricultural Laboratory and Research Center Public a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Asia Medical and Agricultural Laboratory and Research Center Public (AMARC) the key facts are: market cap ฿1.3B, P/E 8.5x, revenue ฿491M, 52-week range 2.12-5.5. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Asia Medical and Agricultural Laboratory and Research Center Public's full fundamentals live
Get Asia Medical and Agricultural Laboratory and Research Center Public's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.